Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 | P01008 | 3/20 | 0.60 |
| ▸ | F10 | P00742 | 6/20 | 0.43 |
| ▸ | FGF1 | P05230 | 4/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 5/20 | 0.35 |
| ▸ | FGF2 | P09038 | 1/20 | 0.35 |
| ▸ | BDNF | P23560 | 2/20 | 0.31 |
| ▸ | PTN | P21246 | 1/20 | 0.31 |
| ▸ | MDK | P21741 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12606391 | 0.91 | SERPINC1 (0.58) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL13039102 | 0.90 | SERPINC1 (0.57) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL14363911 | 0.90 | SERPINC1 (0.57) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL12606386 | 0.87 | SERPINC1 (0.54) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL12606421 | 0.86 | SERPINC1 (0.53) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL12606383 | 0.84 | SERPINC1 (0.51) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL13039108 | 0.82 | SERPINC1 (0.54) | SERPINC1F10FGF1F2HPSE | |
| Idraparinux SCHEMBL29382311 | 0.81 | SERPINC1 (0.85) | SERPINC1F10FGF1F2HPSE | |
| SCHEMBL29407493 | 0.81 | SERPINC1 (0.85) | SERPINC1F10FGF1F2HPSE | |
| Idraparinux SCHEMBL427808 | 0.81 | SERPINC1 (0.85) | SERPINC1F10FGF1F2HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943595-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI-AVENTIS (FR) | 2011-05-17 | — | — | US | disclosed |